In this regard, degradation of two well-known ADAMTS-5 substrates such as brevican [39] and aggrecan [40] facilitate tumor progression in glioblastoma and laryngeal carcinoma, respectively. This evidence concerns the gene ADAMTS5 and glioblastoma.